Cargando…
Development and validation of nomograms for predicting survival in differentiated thyroid cancer patients with or without radioiodine therapy
OBJECTIVE: This study aimed to establish and validate the nomograms for predicting overall survival (OS) probabilities in differentiated thyroid cancer (DTC) patients who received and did not receive radioiodine therapy (RAI), respectively. METHODS: In this study, 11, 099 patients diagnosed with DTC...
Autores principales: | Ran, Bingyu, Gong, Jian, Shang, Jingjie, Wei, Feng, Xu, Hao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034318/ https://www.ncbi.nlm.nih.gov/pubmed/36969066 http://dx.doi.org/10.3389/fonc.2023.1054594 |
Ejemplares similares
-
A user-friendly nomogram for predicting radioiodine refractory differentiated thyroid cancer
por: Meng, Chao, et al.
Publicado: (2023) -
Exploratory Analysis to Predict Optimal Tumor Burden for Starting Lenvatinib in Patients With Radioiodine-Refractory Differentiated Thyroid Cancer
por: Suzuki, Chiaki, et al.
Publicado: (2021) -
Development and validation of nomograms to predict survival in patients with invasive micropapillary carcinoma of the breast
por: Cheng, Yixin, et al.
Publicado: (2023) -
Construction and validation of a nomogram to predict overall survival in patients with breast sarcoma
por: Cheng, Yixin, et al.
Publicado: (2022) -
Radioiodine refractoriness score: A multivariable prediction model for postoperative radioiodine‐refractory differentiated thyroid carcinomas
por: Li, Genpeng, et al.
Publicado: (2018)